The Polymorphism in Interleukin-6-597 G/A Gene and their Levels on Type 2 Diabetic Patients
DOI:
https://doi.org/10.3889/oamjms.2021.5632Keywords:
Interleukin-6-597 G/A Gene Polymorphism, Interleukin-6 levels, Type 2 Diabetic PatientsAbstract
BACKGROUND: Interleukin-6 (IL-6) pro-inflammatory cytokines play a role in the pathogenesis of inflammatory reactions in type 2 diabetes mellitus (T2DM). The -597G/A is one of IL-6 gene polymorphisms that are associated with the T2DM risk.
AIM: This study aimed to observe the polymorphism in IL-6-597 G/A gene and their levels on type 2 diabetic patients at Universitas Sumatera Utara Hospital.
MATERIALS AND METHODS: IL-6 -597 G/A gene polymorphisms and levels were done in 80 type 2 diabetic patients. The levels of IL-6 were performed by enzyme-linked immunosorbent assay method. Analysis of IL-6-597 G/A gene polymorphism was done using polymerase chain reaction (PCR) and restriction fragment length polymorphism. The PCR products were cut by FokI restriction enzyme and then visualized with 4% agarose.
RESULTS: This study showed that the genotype frequency of GG and GA was 97.5 % and 2.5 %, respectively; however, no A/A genotype shown in this population. IL-6 levels were higher in GG genotype group compare to GA+AA genotype group, with the association were significant (p < 0.05).
CONCLUSION: This study indicated that GG genotype was common genotype in the IL-6-597 G/A gene polymorphism and the polymorphism was significantly with the IL-6 levels.
Downloads
Metrics
Plum Analytics Artifact Widget Block
References
Cho N, Shaw JE, Karuranga S, Huang Y, da Rocha Fernandes JD, Ohlrogge AW, et al. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2017;19:43-6. https://doi.org/10.1016/j.diabres.2018.02.023
Riset Kesehatan Dasar. 2018. Hasil Utama Riskesdas Balitbangkes Kementerian Kesehatan. Available online from: https://www.litbang.kemkes.go.id/laporan-riset-kesehatan-dasarriskesdas/ [Last accessed: 20 Sep 2020].
Chan M. Global Report on Diabetes. Vol. 58. Geneva: World Health Organization; 2014. p. 1-88.
American Diabetic Association. 2 Classification and diagnosis of diabetes: Standards of medical care in diabetes. Diabetes Care. 2018;41(1):S137-43. https://doi.org/10.2337/dc19-s002
Fauci AS, Kasper DL, Longo DL, Braunwald E, Hauser SL, Jameson JL, et al. Harrison’s Principles of Internal Medicine. 17th ed., Vol. 38. New York: McGraw-Hill Education; 2008. p. 932-33. https://doi.org/10.1111/j.1445-5994.2008.01837.x
Rodwell VW, Bender DA, Botham KM, Kennelly PJ, Weil PA. Harper’s Illustrated Biochemistry. New York: McGraw-Hill Education; 2015. p. 693.
Fernández-Real JM, Broch M, Vendrell J, Gutiérrez C, Casamitjana R, Pugeat M, et al. Interleukin-6 gene polymorphism and insulin sensitivity. Diabetes. 2000;49(3):517-20. https://doi.org/10.2337/diabetes.49.3.517 PMid:10868978
Banerjee M, Saxena M. Genetic polymorphisms of cytokine genes in type 2 diabetes mellitus. World J Diabetes. 2014;5(4):493. https://doi.org/10.4239/wjd.v5.i4.493 PMid:25126395
Ismail S, Essawi M. Genetic polymorphism studies in humans. Middle East J Med Genet. 2012;1(2):57-63. https://doi.org/10.1097/01.mxe.0000415225.85003.47
Kristiansen OP, Mandrup-Poulsen T. Interleukin-6 and diabetes: The good, the bad, or the indifferent? Diabetes. 2005;54(2):S114- 24. https://doi.org/10.2337/diabetes.54.suppl_2.s114 PMid:16306329
Illig T, Bongardt F, Schopfer A, Muller-Scholze S, Rathmann W, Koenig W, et al. Significant association of the interleukin-6 gene polymorphisms C-174G and A-598G with Type 2 diabetes. J Clin Endocrinol Metab. 2004;89(10):5053-8. https://doi.org/10.1210/ jc.2004-0355 PMid:15472205
Boeta-Lopez K, Duran J, Elizondo D, Gonzales E, Rentfro A, Schwarzbach AE, et al. Association of interleukin-6 polymorphisms with obesity or metabolic traits in young Mexican-Americans. Obes Sci Pract. 2018;4(1):85-96. https://doi.org/10.1002/osp4.138 PMid:29479468
Scheller J, Chalaris A, Schmidt-Arras D, Rose-John S. The pro-and anti-inflammatory properties of the cytokine interleukin-6. Biophys Acta Mol Cell Res. 2011;1813(5):878-88. https://doi.org/10.1016/j.bbamcr.2011.01.034 PMid:21296109
Dosseva-Panova V, Mlachkova A, Popova C, Kicheva M. Evaluation of interleukin-6, lymphotoxin-α and TNF-α gene polymorphisms in chronic periodontitis. J IMAB Ann Proc Sci Papers. 2015;21(3):868-75. https://doi.org/10.5272/jimab.2015213.868
Tanaka T, Narazaki M, Kishimoto T. IL-6 in inflammation, immunity, and disease. Cold Spring Harb Perspect Biol. 2014;6(10):16295-6. https://doi.org/10.1101/cshperspect.a028456 PMid:25190079
Naseem S, Iqbal R, Munir T. Role of interleukin-6 in immunity : A review. Int J Life Sci Res. 2016;4(2):268-74.
Pan M, Gao SP, Jiang MH, Guo J, Zheng JG, Zhu JH. Interleukin 6 promoter polymorphisms in normal Han Chinese population: Frequencies and effects on inflammatory markers. J Investig Med. 2011;59(2):272-6. https://doi.org/10.2310/jim.0b013e318206ffad PMid:21157373
Gao SP, Liang S, Pan M, Sun RL, Chen C, Luan H, et al. Interleukin-6 genotypes and serum levels in Chinese Hui population. Int J Clin Exp Med. 2014;7(9):2851-7. PMid:25356148
Karki R, Pandya D, Elston RC, Ferlini C. Defining mutation and polymorphism in the era of personal genomics. BMC Med Genomics. 2015;8(1):1-7. https://doi.org/10.1186/s12920-015-0115-z PMid:26173390
Teama S. DNA polymorphisms: DNA-based molecular markers and their application in medicine. In: Liu Y, editor. Genetic Diversity and Disease Susceptibility. London, UK: Intechopen; 2018. p. 25. https://doi.org/10.5772/intechopen.79517
Hildreth CJ. Inflammation and diabetes. JAMA. 2008;300(21):2476. https://doi.org/10.1001/jama.2008.737
Downloads
Published
How to Cite
License
Copyright (c) 2021 Zaimah Z Tala, Nurfida Khairina Arrasyid, Sanny Sanny, Mutiara Indah Sari (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
http://creativecommons.org/licenses/by-nc/4.0
